3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
9
Breast Neoplasms
6
Ovarian Neoplasms
5
Prostatic Neoplasms
3
Papillomavirus Infections
3
Endometrial Neoplasms
3
Triple Negative Breast Neoplasms
2
Genital Neoplasms, Female
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Stage IB Cervical Cancer FIGO 2018
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Lung Neoplasms
1
Kidney Neoplasms
1
Gynecologic Cancer
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Disease
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
Paclitaxel
2
Carboplatin
2
selinexor
1
pazopanib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Pregnancy Tests
1
Naproxen
1
Human Papillomavirus DNA Tests
1
GX-188 vaccine
1
Filgrastim
1
Educational Status
1
Drug Therapy
1
Colposcopy
1
Biopsy
1
Anesthesia, General
1
Acetic Acid
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Diseases
×
Educational Status
×
Gynecologic
×
Clear all
NCT04679675
2023-09-18
STEP
Kaiser Permanente
Phase NA
Completed
32,771 enrolled
11 charts